Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Iscience|July 2, 2025
Enhanced reverse zoonotic potential and immune evasion by omicron JN.1 variantJiaxin Hu, Fuwen Zan, Yixin He, et al.
Biomaterials|May 12, 2012
Promotion of the induction of cell pluripotency through metabolic remodeling by thyroid hormone triiodothyronine-activated PI3K/AKT signal pathwayMengfei Chen, He Zhang, Jie Wu, et al.
Acta Pharmaceutica Sinica. B|July 15, 2026
AI-powered therapeutic aptamer drug discovery: Targeting the CT-domain of CTGF for duchenne muscular dystrophyShanshan Yao, Xin Yang, Meishen Ren, et al.
Npj Viruses|March 2, 2026
Prolonged dysregulation and pathological changes in the upper respiratory tract of SARS-CoV-2 infected hamstersFeifei Liu, Yao Xia, Andrew Chak-Yiu Lee, et al.
Nature Medicine|January 31, 2012
A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapyGe Zhang, Baosheng Guo, Heng Wu, et al.
Cell Reports. Medicine|April 24, 2026
Intracellular sclerostin promotes tumor progression and metastasis as a potential therapeutic target in triple-negative breast cancerMeiheng Sun, Hang Luo, Shuangying Qiao, et al.
Journal of Medical Virology|February 19, 2024
Type-II IFN inhibits SARS-CoV-2 replication in human lung epithelial cells and ex vivo human lung tissues through indoleamine 2,3-dioxygenase-mediated pathwaysDong Yang, Jasper Fuk-Woo Chan, Chaemin Yoon, et al.
Ebiomedicine|December 15, 2023
Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tractBingjie Hu, Jasper Fuk-Woo Chan, Yuanchen Liu, et al.
Nature Communications|December 11, 2025
Pathogenicity, virological features, and immune evasion of SARS-CoV-2 JN.1-derived variants including JN.1.7, KP.2, KP.3, and KP.3.1.1Jialu Shi, Xiaoyu Zhao, Xiaohui Jin, et al.
Nature Communications|October 8, 2024
Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3Yuanchen Liu, Xiaoyu Zhao, Jialu Shi, et al.
Pageof 11